MedTrace Logo

Maternal Characteristics Associated With Child Growth and Adiposity

NCT05798676 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2025-12-26

No results posted yet for this study

Summary

The goal of this observational study is to investigate the concentrations of leptin, insulin, liver expressed antimicrobial peptide 2 (LEAP2), and cortisol in plasma and breast milk and their relationship with eating behavior, growth, adiposity and with the levels of these hormones in infants, comparing mothers with normal weight and with pre-pregnancy overweight/obesity. The main question\[s\] it aims to answer are:

* Are maternal hormones associated with child growth and adiposity
* Are maternal hormone receptors associated with child growth and adiposity
* Are infant hormones and their receptors associated with child growth and adiposity
* Are maternal and infant hormones and their receptors associated with child eating behavior Participants will provide milk and blood samples. Researchers will compare mothers with normal weight and with pre-pregnancy overweight/obesity to see if there are differences in child growth and adiposity .

Conditions

Interventions

OTHER

overweight/obesity

the consequences of maternal pregestational overweight/obesity on infant´s growth and adiposity will be studied

Sponsors & Collaborators

  • Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri

    lead OTHER

Principal Investigators

  • Maria F Andreoli, BsC · Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-02
Primary Completion
2028-03-31
Completion
2028-03-31

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05798676 on ClinicalTrials.gov